Commentary on "Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease" by Zimran et al
Blood Cells Mol Dis
.
2013 Feb;50(2):138-9.
doi: 10.1016/j.bcmd.2012.09.007.
Epub 2012 Oct 18.
Author
Ozlem Goker-Alpan
1
Affiliation
1
Lysosomal Disorders Research and Treatment Unit, Center for Clinical Trials, O&O Alpan, Fairfax, VA, USA.
[email protected]
PMID:
23083682
DOI:
10.1016/j.bcmd.2012.09.007
No abstract available
Publication types
Comment
MeSH terms
Ambroxol / therapeutic use*
Female
Gaucher Disease / drug therapy*
Humans
Male
Substances
Ambroxol